Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Net Income: 2012-2025

Historic Net Income for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $108.6 million.

  • CorMedix's Net Income rose 4002.28% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year increase of 496.27%. This contributed to the annual value of -$17.9 million for FY2024, which is 62.52% up from last year.
  • CorMedix's Net Income amounted to $108.6 million in Q3 2025, which was up 433.49% from $20.3 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Net Income registered a high of $108.6 million during Q3 2025, and its lowest value of -$14.5 million during Q1 2024.
  • Its 3-year average for Net Income is $10.0 million, with a median of -$6.3 million in 2023.
  • Its Net Income has fluctuated over the past 5 years, first plummeted by 60.27% in 2023, then spiked by 4,002.28% in 2025.
  • Over the past 5 years, CorMedix's Net Income (Quarterly) stood at -$7.8 million in 2021, then fell by 5.36% to -$8.2 million in 2022, then crashed by 42.18% to -$9.7 million in 2023, then soared by 71.45% to $13.5 million in 2024, then skyrocketed by 4,002.28% to $108.6 million in 2025.
  • Its Net Income stands at $108.6 million for Q3 2025, versus $20.3 million for Q2 2025 and $20.6 million for Q1 2025.